This supplement to The American Journal of Managed Care provides an overview of the considerable clinical, quality-of-life (QoL), and economic toll associated with obesity and obesity-related comorbidities. Also discussed are the cost-effectiveness of interventions to treat obesity and the impact of weight loss on health outcomes, costs, and QoL.This supplement was supported by VIVUS, INC.
Caroline M. Apovian, MD
Nutrition and Weight Management Center
Boston Medical Center
Professor of Medicine
Boston University School of Medicine
Caroline M. Apovian, MD, reports relationships with the following organizations:
Advisory boards: Amylin Pharmaceuticals, Arena Pharmaceuticals, Johnson & Johnson, Merck, Nutrisystem, sanofi-aventis, and Zafgen
Grants: Amylin Pharmaceuticals, Dr. Robert C. and Veronica Atkins Foundation, Eli Lilly and Company, MetaProteomics, Orexigen Therapeutics, Pfizer, and sanofi-aventis
Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.